Logo
Extra II 1 x 1 ml

Extra II 1 x 1 ml

Klmedi

Dermal filler
  • Manufactured in South Korea by KLmedi using EP Grade hyaluronic acid and cross Linking technology (TSC).
  • Distributed through authorised aesthetic device/filler wholesalers, typically restricted to licensed professionals only.
  • Compliance with cosmetic/medical device regulations as applicable in destination countries; CE/EC origin claimed by some distributors for importation into EU/UK markets.
Hyaluronic acid dermal filler (facial)

Description

Extra II is a hyaluronic acid–based dermal filler presented as a 1 ml syringe, using patent micro-bead technology with cross-linked HA. It is designed for facial volumising and contouring, targeting deeper wrinkles, nasolabial folds, lip augmentation and general facial shaping. The gel is formulated without lidocaine and supplied with two 27G 13 mm needles for injection by trained professionals. The filler’s cross-linked HA micro-bead structure delivers a moderate-to-high viscosity gel suitable for deep dermis to mid-dermis injection, offering volume, lift and definition where needed. According to distributors, results typically last 6–12 months.

Bnefits

  • Provides volume and structure to deep facial wrinkles, folds and depressed areas (e.g., nasolabial folds, marionette lines).
  • Suitable for lip augmentation and contouring to improve shape and fullness of lips.
  • Helps contour and shape facial features, offering natural-looking enhancement and definition.
  • Uses micro-bead cross-linked HA technology to deliver stable, mouldable gel that integrates well into facial tissues.
  • Hyaluronic acid-based filler, which can attract water and help maintain hydration and volume over time.
  • Medium to long-lasting results (commonly 6–12 months) depending on injection depth, patient metabolism and lifestyle.
  • Supplied with needles, ready-to-use, and does not include lidocaine, allowing practitioner discretion in anaesthesia protocols.

Indications

  • Deep wrinkles and facial folds (e.g., nasolabial folds, marionette lines, frown lines).
  • Lip augmentation and shaping to add volume or correct asymmetry.
  • Facial contouring and volumisation in areas requiring moderate to significant lift and structure.
  • Restoration of volume loss due to ageing in mid-face, cheeks or perioral area.
  • Patients seeking non-permanent enhancement with HA filler rather than long-term implants.

Composition

  • Cross-linked hyaluronic acid (HA), non-animal origin.
  • Monophasic gel composed of patented micro-beads to provide viscosity and stability.
  • No lidocaine in the formulation (lidocaine-free).
  • Standard sterile aqueous filler gel excipients and buffer components (exact proprietary formulation not publicly disclosed).

Formulation

  • Injectable hyaluronic acid dermal filler.
  • Monophasic micro-bead HA gel using cross-linking (Third-Step Cross-Linking / TSC-based process as in the Extra filler family) for enhanced viscosity and longevity.
  • Supplied in 1 ml pre-filled syringe for single-patient use.
  • Intended for deep dermis to mid-dermis injection depending on treatment area and indication.

Packaging

  • 1 ml prefilled syringe labelled “Extra II – 1 x 1 ml”.
  • Two 27G 13 mm needles included with the syringe, for immediate injection.
  • Sterile, ready-to-use packaging shipped through authorised aesthetic supply distributors for clinical use.

Usage

  • For professional use only by qualified medical or aesthetic practitioners experienced with dermal fillers.
  • Perform full patient evaluation and obtain informed consent prior to treatment.
  • Prepare skin with antiseptic and optional topical anaesthesia as per clinic protocol.
  • Use one of the supplied 27G 13 mm needles to inject the filler into the deep dermis or mid-dermis, depending on the target area and indication.
  • Deposit small aliquots of filler gradually, with appropriate molding / massage if required to achieve desired contour and symmetry.
  • Avoid injection into blood vessels; aspirate before injection and inject slowly with minimal pressure.
  • Advise patient on post-procedure care: avoid excessive pressure, massage, heat or strenuous activity for at least 24–48 hours; recommend sun protection and gentle skin care.
  • Monitor for signs of complications (swelling, redness, bruising, asymmetry) and schedule follow-up as per standard dermal filler protocol.

Contraindications

  • Known hypersensitivity to hyaluronic acid or any component of the filler formulation.
  • Active skin infection, inflammation, acne, or open wounds in the planned injection area.
  • History of severe allergic reactions or anaphylaxis to dermal fillers.
  • Pregnancy or breastfeeding, due to lack of safety data for facial fillers in these populations.
  • Autoimmune diseases or immunocompromised status, unless assessed carefully by treating physician.
  • Unrealistic patient expectations, or contraindications based on individual facial anatomy or prior procedures (e.g., severe scar tissue).

Adverse Effects

  • Common, transient: redness, swelling, bruising, pain or tenderness at injection sites.
  • Mild temporary asymmetry or unevenness may occur, requiring touch-up or correction.
  • Formation of small lumps, nodules or over-correction if filler is over-injected or unevenly distributed.
  • Rare hypersensitivity / allergic reactions (redness, itching, swelling) in sensitive individuals.
  • Risk of vascular occlusion if product is inadvertently injected into or compresses a vessel; may lead to skin necrosis or more serious complications if not promptly recognised and managed.
  • Infection risk if aseptic technique or sterility protocols are not strictly followed.

Storage Conditions

  • Store at room temperature, protected from direct sunlight and extremes of temperature, as per manufacturer instructions.
  • Keep syringe in original sealed sterile packaging until immediately prior to use.
  • Do not freeze or expose to excessive heat or UV light.
  • Check expiry date before use; do not use if packaging is damaged or expired.
  • Store out of reach of unauthorised persons and in compliance with medical device storage regulations.

Duration

Effects typically last between 6 and 12 months, depending on injection technique, treated area, patient metabolism and lifestyle factors.

Onset

Volume correction and contour effects are visible immediately following injection; final integration and settling of the filler gel generally stabilises over 1\u20132 weeks as any swelling subsides.

Browse more Dermal filler

Top Treatments

Top Cities in the UK